Search
Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing - 05/31/2019 - 05/31/2019
… Background The Food and Drug Administration held a public hearing to obtain scientific data and information about the … Containing Cannabis or Cannabis-Derived Compounds Public Hearing. Transcript Submitting Comments FDA established a docket for public comment on this hearing.The docket number is FDA-2019-N-1482 . On June 20, …
Remarks by Acting Commissioner Ned Sharpless at the FDA Public Hearing on The Future of Biosimilar Insulin - 05/13/2019
… icials/remarks-acting-commissioner-ned-sharpless-fda-public-hearing-future-biosimilar-insulin-05132019 … White Oak, MD … thank you for joining us for today’s very important Public Hearing. The world of public health has never been as … treatments and devices. The subject of today’s public hearing -- facilitating the efficient development of …
Facilitating Price Competition and Innovation in the Biological Products Marketplace Public Hearing - 09/04/2018
… ition-and-innovation-biological-products-marketplace-public-hearing … The Food and Drug Administration (FDA or the Agency) is announcing a public hearing on FDA's approach to enhancing competition and … Administration (FDA or the Agency) is announcing a public hearing on FDA's approach to enhancing price competition and …
Remarks by Dr. Sharpless at the FDA Public Hearing on Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds - 05/31/2019
… Thank you for joining FDA today for this public hearing titled “Scientific Data and Information About … attendees, and those unable to participate in today’s hearing – to submit comments to our docket on this topic, … group to address these data gaps specifically. You’ll be hearing more from this group in the months to come. FDA is …
The Future of Insulin Biosimilars: Increasing Access and Facilitating the Efficient Development of Biosimilar and Interchangeable Insulin Products - 05/13/2019 - 05/13/2019
… insulin needed to survive. The FDA is holding this public hearing to receive input from stakeholders as the Agency … OMPTFeedback@fda.hhs.gov at least 7 days before the public hearing. Background Information Federal Register notice Final … . … Office of the Commissioner … FDA public hearing to receive input as the Agency prepares for the …
Hearing on an Emerging Disease Threat: How the U.S. Is Responding to COVID-19, the Novel Coronavirus - 03/03/2020 -
… and Pensions Committee, March 3, 2020 … Stephen Hahn … Hearing on an Emerging Disease Threat: How the U.S. Is …
Hemp Production and the 2018 Farm Bill - 07/25/2019
… cannabis products and their derivatives, we held a public hearing on May 31, 2019. The goal of the public hearing was to obtain scientific data and information about … containing cannabis or cannabis-derived compounds. The hearing was attended in person by more than 600 people, with …
Remarks at the National Industrial Hemp Council 2019 Hemp Business Summit - 08/13/2019
… to the legal landscape. And increasingly, we’ve been hearing from a broad range of stakeholders who are eager to … That group has been busy, too. In May, FDA held a public hearing on cannabis issues, including but not limited to CBD. … stakeholders, and the public response was tremendous. The hearing was attended by more than 600 people in person, with …
Remarks by Lauren Silvis, Chief of Staff, to the Consumer Health Products Association Regulatory, Scientific, and Quality Conference - 05/21/2019
… the DFL and labeling are not sufficient. We’re open to hearing from sponsors who want to pursue this approach in the … the regulatory path forward, FDA is holding a public hearing on May 31 to obtain additional scientific data and … related to cannabis and cannabis-derived compounds. This hearing is expected to be an important step in our continued …
Public Meeting: Optimizing FDA’s Use of and Processes for Advisory Committees - 06/13/2024
… advisory committees, we are interested in more broadly hearing from all parties interested in the advisory committee … and patients may also participate in the open public hearing or submit written comments to the docket for a …
Remarks by Associate Commissioner Mark Abdoo at the Asia-Pacific Economic Cooperation Medical Product Supply Chain Dialogue - 04/25/2023
… ways to incentivize quality manufacturing. You’ll soon be hearing about the Asia Pacific Economic Cooperation’s Roadmap … looks to be an outstanding conference. I look forward to hearing from the next speakers. Thank you. … Office of the …
Final All Hands Meeting with Dr. Gottlieb - 04/04/2019
… times in the past two years. The only major Congressional hearing where I didn’t testify was the one hearing on OTC drug reform where Janet Woodcock told me I …
Pediatric Stakeholder Meeting - A Public Meeting - 11/21/2019
… at the meeting will include, but not be limited to: Hearing from patients/parents and patient/parent groups, …
Promoting Effective Drug Development Programs: Opportunities and Priorities for FDA’s Office of New Drugs - 11/07/2019 - 11/07/2019
… or additional policy development. We are interested in hearing specific recommendations for topics where further …
Remarks by Lowell Schiller, JD at the Council for Responsible Nutrition Conference - 11/7/2019 - 11/07/2019
… about the future, we’re having a broad conversation and hearing the full range of perspectives. To this end, we held … an ingredient is introduced to the market without FDA ever hearing about it, then that undermines the integrity of the …
FDA Acting Commissioner's Remarks to the 2019 FDLI Annual Conference - 05/02/2019
… I also came prepared. Later today, after lunch, you’ll be hearing from FDA’s top lawyer, Stacy Amin, and I’m sure … in small quantities in blister packaging. You’ll be hearing more about this in the near future. An area I find …
FDA Public Meeting on Responsible Innovation in Dietary Supplements - 05/16/2019
… of Dietary Supplement Programs is looking forward to hearing your suggestions on how we might reshape our …
Remarks by Associate Commissioner Mark Abdoo at the FDA-OECD workshop on illicit trade in health products, September 15, 2022 - 09/15/2022
… microcosm of a whole-of-government effort! What you’ll be hearing about over the next two days marks the culmination of …
Remarks by Associate Commissioner Mark Abdoo at the Food & Drug Law Institute 2023 Conference - 05/18/2023
… with industry and other partners. I look forward to hearing from my fellow panel members and addressing your …
Flu Season: U.S. Public Health Preparedness and Response - 12/04/2019
… influenza vaccines. As noted by others at today’s hearing, the key here is being able to produce large amounts …
Remarks by Dr. Woodcock to the Regulatory Education for Industry Conference - 07/19/2021
… time, CBER, are represented at this conference. You’ll be hearing from all three center directors in the plenary …
Remarks by Commissioner Califf to the 2022 FDLI Annual Conference - 06/14/2022
Cannabis Policies For the New Decade - 01/15/2020
… ongoing efforts including feedback from a recent FDA hearing and information and data gathering through a public …
Remarks by FDA Commissioner Robert M. Califf to the Coalition for Health AI (CHAI) - 03/05/2024
… data as a “one-off” activity. Not surprisingly, I’m hearing that the “effectiveness” metric being used by health …
Protecting Americans from COVID-19 Scams (written testimony only) - 07/21/2020
… for the invitation to provide a written statement for the hearing. Footnote 1. When the U.S. Department of Agriculture …